Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


High-Definition Erenna® Technology; Powered by Singulex

Product Description

Erenna_w_screen_clear.gif
Singulex, Inc., is a leader in advanced biomarker research, deploying high precision, high sensitivity, digital immunoassay technology to enable groundbreaking discovery, innovate therapies and improved healthcare.

The Erenna® Immunoassay System, powered by Singulex's patented single-molecule detection technology, accurately, precisely and reliably quantifies low-abundance biomarkers at or below sub-picogram concentrations – even in healthy individuals. This unique high-definition technology enhances the clinical utility of biomarkers and allows researchers to gain insights into drug safety and efficacy.

  • Quantifying the Previously Undetectable
  • Uncovering Novel Biology
  • Accelerating Discovery
  • Generating Relevant Data
  • Requiring Fewer Data Points for Critical Decision Making
  • Reducing Program Costs & Improving ROI

The Erenna Immunoassay System includes fully equipped instrumentation, integrated and prepared reagents for high-precision, ultrasensitive immunoassays, and dedicated Sgx link™ software to automatically analyze data and display detailed assay reports. 

The Singulex Solution is flexible to meet your needs and includes the Erenna Immunoassay System, High-Definition Immunoassays and a full range of Custom Services;  Sample Testing, Assay Development and  Antibody Derivatization Services; to accelerate your clinical trials & therapeutics management, and translational life science research.

Unless otherwise noted, Singulex products are for research use only and not intended for diagnostics use.

Contact for More Information.

Product High-Definition Erenna® Technology; Powered by Singulex
Company Singulex - Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Singulex - Product Directory
1701 Harbor Bay Parkway, Alameda, California 94502, USA

Tel: +1.888.995.6955
Fax: +1.510.995.9090
Email: info@singulex.com



Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!